Akums Drugs & Pharmaceuticals Ltd. Fundamental & Technical Research, Share Price Today

NSE : AKUMS
NIFTY : Nifty 500

About Company

Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the leading CDMOs in India, the company owns the intellectual property for the manufacturing processes of several of its formulations, and its core business is focused on providing end-to-end product development and manufacturing solutions to its clients.

Market Cap. ₹6,633 Cr.

52 Week - High/Low ₹1,176/405

P/E Ratio 46.82

P/B Ratio 46.11

Enterprise Value ₹8,009 Cr.

ROE % -72.66

RSI Value 28.03

EMA 50 515.66

EMA 200 505.79

Net Profit -165 Cr.

Net Profit 3year growth 13.77 Cr.

Net Profit 3 year (back) -145 Cr.

Debt to Equity 1.57 %

EPS Growth TTM -219.68 %

Current Ratio 1.06 %

100 Day SMA 563 Rs.

200 Day SMA 689 Rs.

21 Day SMA 487 Rs.

50 Day SMA 513 Rs.

Book Value 9 Rs.

EV/EBITDA Ratio 38

QoQ EPS Growth -18 %

QoQ Operating Profit Growth -21 %

QoQ Sales Growth 3 %

Sales Latest Quarter 337 Cr.

YoY Sales Growth -25 %

Market Cap. ₹6,633 Cr.

52 Week - High/Low ₹1,176/405

P/E Ratio 32.82

P/B Ratio 9.35

Enterprise Value ₹7,818 Cr.

ROE % 0.11

RSI Value 28.03

EMA 50 515.66

EMA 200 505.79

Net Profit -4 Cr.

Net Profit 3year growth N/A

Net Profit 3 year (back) 123 Cr.

Debt to Equity 0.69 %

EPS Growth TTM 465.64 %

Current Ratio 1.6 %

100 Day SMA 563 Rs.

200 Day SMA 689 Rs.

21 Day SMA 487 Rs.

50 Day SMA 513 Rs.

Book Value 45 Rs.

EV/EBITDA Ratio 19

QoQ EPS Growth -0 %

QoQ Operating Profit Growth 1 %

QoQ Sales Growth -2 %

Sales Latest Quarter 1,010 Cr.

YoY Sales Growth -14 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages